Antibiotic resistance has emerged as a global health crisis, threatening the effectiveness of current antimicrobial therapies and complicating the treatment of infectious diseases. This study provides a comprehensive analysis of antibiotic resistance patterns from a pharmaceutical perspective, focusing on the mechanisms by which bacteria develop resistance and the contributing factors such as inappropriate prescribing practices, suboptimal dosing, and patient non-compliance. Using data collected from clinical samples, we assessed resistance trends in key bacterial pathogens, identifying the most resistant strains and evaluating the efficacy of commonly used antibiotics.
Our findings highlight significant resistance to several first-line antibiotics, particularly in hospital-acquired infections. The study underscores the importance of continuous surveillance, adherence to antibiotic stewardship programs, and the development of new pharmaceutical strategies to combat resistance. Recommendations are made for optimizing antibiotic use through personalized therapy and reinforcing guidelines for infection control. This research provides valuable insights into the growing challenge of antibiotic resistance and offers potential solutions to guide future pharmaceutical interventions and public health policies.